When to Stop Atropinization? Key Considerations in Medications and Pharmacology
•
4 min read
According to the CDC, the key endpoint for atropinization is the resolution of excessive muscarinic symptoms like bronchorrhea, and not unreliable signs like pupillary changes or heart rate alone. A clear understanding of **when to stop atropinization** is crucial for preventing both undertreatment and potentially fatal over-atropinization, particularly in emergency and critical care settings.